Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by losingmyshirton Oct 24, 2020 5:43pm
181 Views
Post# 31777288

The long and short of it is>

The long and short of it is>In all seriousness folks. ( I will tout Dentures for cats in a seperate post)

We gambled on a TSXV penny stock, and we have lost.  So what is the big deal here?
For those that have played pennies stocks for years, it's the risk that we take.
Kalyteran and the pumpers keep talking about nitric oxide and that is all fine and dandy but  Nitric Oxide has been in use for a long time and yes it does what it is supposed to do.

At issue here is Kaly's miraculous R107. Show me that studies and trials have been done on R107 in humans..You cannot. The reason that you can't find any human trials for R107 is because there are no trials. And why are there no trials in process?  It's simple. There isn't an interest.  Why no interest?  Have you ever heard that phrase IF IT AIN'T BROKE DON'T FIX IT.

The medical world is happy with Nitric Oxide being administered in a gaseous form and they see no need to look for a new way.

Please stop talking about the benefits of Nitric Oxide and how Kaly will blow everyone away with R107. It will not, and cannot happen.


And now, let me return to a more pressing issue which is, Finding the correct dentures for your cat.
https://kittydentures.wordpress.com/dentures/













<< Previous
Bullboard Posts
Next >>